March 16, 2020 / 6:42 PM / 20 days ago

BRIEF-Abivax FY Operating Loss Widens To 33.3 Million Euros

March 16 (Reuters) - Abivax SA:

* 2020 OUTLOOK: TREASURY FUNDING OPERATIONAL ACTIVITIES UNTIL THE END OF SECOND QUARTER 2020

* FY OPERATING LOSS EUR 33.3 MILLION VERSUS LOSS OF EUR 19.1 MILLION YEAR AGO

* FY LOSS FOR THE PERIOD EUR 30.6 MILLION VERSUS LOSS OF EUR 15.8 MILLION YEAR AGO

* ON CORONAVIRUS: TAKES NECESSARY MEASURES TO LIMIT IMPACT ON ITS ONGOING CLINICAL STUDIES AND TO ENSURE PATIENT ACCESS TO ABX464 AND ABX196

* ON CORONAVIRUS: ABIVAX EXPECTS SEVERAL OF ITS ANTIVIRAL COMPOUNDS TO BE TESTED AGAINST COVID-19

* 2020 OUTLOOK: ABX464-103 FIRST RESULTS OF PHASE 2-B TEST ARE EXPECTED AT LAST 2020 QUARTER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below